Page 3 - Repligen Xcell News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Repligen xcell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Repligen Xcell Today - Breaking & Trending Today

Decoding Repligen Corp (RGEN): A Strategic SWOT Insight

Unveiling the Financial and Strategic Position of Repligen Corp in the Bioprocessing Landscape ....

Repligen Corp , Danaher Corporation , Thermo Fisher Scientific Inc , Product Portfolio , Commercial Presence , Key Customers , Market Pressures , Biologics Market , Regulatory Challenges , Market Presence , Global Reach , Ioprocessing Products ,

Repligen (NASDAQ:RGEN) Shares Gap Down to $199.73

Repligen Co. (NASDAQ:RGEN – Get Free Report) gapped down prior to trading on Wednesday . The stock had previously closed at $199.73, but opened at $187.80. Repligen shares last traded at $198.30, with a volume of 185,706 shares changing hands. Wall Street Analysts Forecast Growth A number of brokerages recently weighed in on RGEN. KeyCorp […] ....

United States , Asia Pacific , Royal Bank , Repligen Co , Repligen Corporation , Repligen Company Profile , Principal Securities Inc , Fortis Capital Advisors , Park Place Capital Corp , Benjaminf Edwards Company Inc , Jpmorgan Chase Co , Get Free Report , Trading Down , Capital Advisors , Place Capital Corp , Principal Securities , North America , Repligen Daily , Nasdaq Rgen ,

DekaBank Deutsche Girozentrale Boosts Holdings in Repligen Co. (NASDAQ:RGEN)

DekaBank Deutsche Girozentrale grew its stake in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 1.5% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,457 shares of the biotechnology company’s stock after buying an additional 159 shares […] ....

United States , Dekabank Deutsche Girozentrale , Stifel Nicolaus , Asia Pacific , First Horizon Advisors Inc , Repligen Co , Royal Bank , Fortis Capital Advisors , Repligen Corporation , Exchange Commission , Daiwa Securities Group Inc , Jpmorgan Chase Co , Free Report , Bank Deutsche Girozentrale , Capital Advisors , Horizon Advisors , Daiwa Securities Group , Securities Group , Get Free Report , North America , Repligen Daily , Nasdaq Rgen , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Repligen (NASDAQ:RGEN) Posts Quarterly Earnings Results, Meets Estimates

Repligen (NASDAQ:RGEN – Get Free Report) released its earnings results on Wednesday. The biotechnology company reported $0.33 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.33, Briefing.com reports. The business had revenue of $155.74 million for the quarter, compared to analyst estimates of $155.38 million. Repligen had a return on equity […] ....

United Kingdom , United States , Asia Pacific , Stifel Nicolaus , Cambridge Investment Research Advisors Inc , Lazard Asset Management , Repligen Corporation , Cerity Partners , Fortis Capital Advisors , Jpmorgan Chase Co , Get Free Report , Capital Advisors , Investment Research Advisors , Asset Management , North America , Repligen Daily , Nasdaq Rgen ,

Repligen Corporation (NASDAQ:RGEN) Q4 2023 Earnings Call Transcript

Repligen Corporation (NASDAQ:RGEN) Q4 2023 Earnings Call Transcript February 21, 2024 Repligen Corporation reports earnings inline with expectations. Reported EPS is $0.33 EPS, expectations were $0.33. Repligen Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, ladies and […] ....

United States , Asia Pacific , Fastest Growing Energy Drink Stocks , Fluid Management , North America , Magic Formula Stocks , Buy Now , Growing Energy Drink Stocks , Fourth Quarter , Operating Margins , Tony Hunt ,